BVX Stock News Bovie Medical Corp (BVX) 3.90 08/02/2014 04:2

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Bovie Medical Corp (BVX) 3.90 $BVX

United Kingdom Surgical Generators Market Outlook to 2020: Key players covered include Covidien, ERBE Elektromedizin and ConMed
M2 - Wed Jul 30, 4:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/db9xbr/united_kingdom) has announced the addition of the "United Kingdom Surgical Generators Market Outlook to 2020" report to their offering. Our new report, "United Kingdom Surgical Generators Market Outlook to 2020", provides key market data on the United Kingdom Surgical Generators market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Electrosurgical RF Generators, Electrocautery Generators, Ultrasonic Generators and Argon Plasma Coagulation Generators. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Surgical Generators market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Companies Mentioned: - Covidien plc - Olympus Corporation - ERBE Elektromedizin GmbH - ConMed Corporation - Medtronic, Inc. - B. Braun Melsungen AG - KLS Martin GmbH & Co. KG - MegaDyne Medical Products, Inc. - Plasma Surgical Limited - Bovie Medical Corporation For more information visit http://www.researchandmarkets.com/research/db...ed_kingdom

Brazil Surgical Generators Market Outlook to 2020: Key players covered include Covidien, ERBE Elektromedizin GmbH and ConMed Corporation.
M2 - Wed Jul 30, 4:03AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qkfdgm/brazil_surgical) has announced the addition of the "Brazil Surgical Generators Market Outlook to 2020" report to their offering. Our new report, "Brazil Surgical Generators Market Outlook to 2020", provides key market data on the Brazil Surgical Generators market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Electrosurgical RF Generators, Electrocautery Generators, Ultrasonic Generators and Argon Plasma Coagulation Generators. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Surgical Generators market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Companies Mentioned: - Covidien plc - Olympus Corporation - ERBE Elektromedizin GmbH - ConMed Corporation - Bovie Medical Corporation - KLS Martin GmbH & Co. KG - Medtronic, Inc. - B. Braun Melsungen AG For more information visit http://www.researchandmarkets.com/research/qk...l_surgical

Bovie Medical Corporation Second Quarter 2014 Earnings Conference Call to be Held on Tuesday, August 5, 2014
Business Wire - Tue Jul 29, 7:30AM CDT
Bovie Medical (NYSE:BVX), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented new surgical product, today announced that it will issue its financial results for the second quarter ended June 30, 2014 following the close of market on Tuesday, August 5, 2014.

Russia Surgical Generators Market Outlook to 2020: Key players covered include Covidien, ERBE Elektromedizin and ConMed
M2 - Fri Jul 25, 3:37AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5nfcrp/russia_surgical) has announced the addition of the "Russia Surgical Generators Market Outlook to 2020" report to their offering. Our new report, "Russia Surgical Generators Market Outlook to 2020", provides key market data on the Russia Surgical Generators market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Electrosurgical RF Generators, Electrocautery Generators, Ultrasonic Generators and Argon Plasma Coagulation Generators. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Surgical Generators market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Reasons to buy - Develop business strategies by identifying the key market categories and segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Companies Mentioned: - Covidien plc - Olympus Corporation - ERBE Elektromedizin GmbH - ConMed Corporation - KLS Martin GmbH & Co. KG - Medtronic, Inc. - B. Braun Melsungen AG - MegaDyne Medical Products, Inc. - Bovie Medical Corporation For more information visit http://www.researchandmarkets.com/research/5n...a_surgical

India Surgical Generators Market Outlook to 2020: Key players covered include Covidien, ERBE Elektromedizin GmbH and ConMed Corporation.
M2 - Fri Jul 25, 3:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/q6d9mz/india_surgical) has announced the addition of the "India Surgical Generators Market Outlook to 2020" report to their offering. Our new report, "India Surgical Generators Market Outlook to 2020", provides key market data on the India Surgical Generators market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Electrosurgical RF Generators, Electrocautery Generators, Ultrasonic Generators and Argon Plasma Coagulation Generators. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Surgical Generators market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Reasons to buy - Develop business strategies by identifying the key market categories and segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Companies Mentioned: - Covidien plc - Olympus Corporation - ERBE Elektromedizin GmbH - ConMed Corporation - B. Braun Melsungen AG - KLS Martin GmbH & Co. KG - Medtronic, Inc. - Bovie Medical Corporation For more information visit http://www.researchandmarkets.com/research/q6...a_surgical

Global Electrosurgery (Generator, Electrosurgical Instruments, Accessories, Surgery) Market 2014-2019 with Covidien, Ethicon and Olympus Corp Dominating
M2 - Fri Jul 11, 2:46AM CDT
Research and Markets (http://www.researchandmarkets.com/research/s98g7k/electrosurgery) has announced the addition of the "Global Electrosurgery (Generator, Electrosurgical Instruments, Accessories, Surgery) Market 2014-2019 with Covidien, Ethicon and Olympus Corp Dominating" report to their offering. Although the mature markets (such as the U.S., Germany, U.K.) hold larger shares in the electrosurgery market, the Asia-Pacific region is expected to grow at the highest CAGR of 8.0% in the forecast period. The global electrosurgery market is highly competitive with a large number of global as well as local market players. As of 2013, the global electrosurgery market was dominated by Covidien plc (Ireland), Ethicon (U.S.), and Olympus Corporation (Japan), which together accounted for 78% of the market. New product launches and partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most of the market players to achieve growth in the electrosurgery market. In this report, the global electrosurgery market has been segmented on the basis of type of product (electrosurgical generators, electrosurgical instruments and accessories, and argon and smoke management systems), and type of surgery (general surgery, gynecology surgery, urologic surgery, orthopedic surgery, cardiovascular surgery, cosmetic surgery, neurosurgery, and others (ENT, dermatology, and ophthalmic surgeries). The electrosurgical instruments and accessories market accounted for the largest share of the global electrosurgery market in 2014, followed by the electrosurgical generators market. Factors such as new product launch, technological advancements, and increasing demand of minimal invasive surgery are stimulating the growth of the electrosurgical instruments and accessories market. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Market Overview 5 Industry Analysis 6 Global Electrosurgery Market, By Product 7 Global Electrosurgery Market, By Type Of Surgery 8 Geographic Analysis 9 Competitive Landscape 10 Company Profiles - B. Braun Melsungen Ag - Bovie Medical Corporation - Bowa-Electronic Gmbh & Co. Kg - Conmed Corporation - Covidien PLC - Erbe Elektromedizin Gmbh - Ethicon (Ethicon, Inc. And Ethicon Endo-Surgery, Inc.) - Kls Martin Group - Olympus Corporation - Utah Medical Products, Inc. For more information visit http://www.researchandmarkets.com/research/s9...trosurgery

Bovie Medical Provides Update on J-Plasma, New Products and Personnel Appointment
Business Wire - Fri Jun 27, 7:00AM CDT
--Core Business to Launch Derm 101 and 102 Devices--

The Global Electrosurgery Market is Expected to Grow at a CAGR of 5.9% from 2014-2019 say's a Report at ReportsnReports.com
PRWeb - Sun Jun 01, 11:31AM CDT
The global electrosurgery market is estimated to grow at a CAGR of 5.9% from 2014 to 2019. Although the mature markets (such as the U.S., Germany, U.K.) hold larger shares in the electrosurgery market, the Asia-Pacific region is expected to grow at the highest CAGR of 8.0% in the forecast period. The growth of the electrosurgery market is driven by factors such as technological advancements in electrosurgical devices, rapidly aging population, increasing demand for laparoscopic surgical procedures, improving healthcare facilities in the emerging countries of the Asia-Pacific and RoW (Rest of the World) regions, geographic expansions of market players across the globe, and government initiatives to fulfill healthcare needs. However, factors such as ongoing healthcare reforms in the U.S., product recalls, and increasing price pressure on the electrosurgical device manufacturers and distributors are restraining the growth of this market. Growing public-private investments by market players in the emerging regions of Asia-Pacific and RoW are creating opportunities for the growth of the electrosurgery market in these regions.

Bovie Medical Names Jack McCarthy Chief Commercialization Officer
Business Wire - Mon Mar 31, 3:39PM CDT
Bovie Medical (NYSE MKT:BVX), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented new surgical product, announced today the appointment of Jack McCarthy, 47, as Chief Commercialization Officer.

Bovie Medical Reports Fourth Quarter and Full Year 2013 Results
Business Wire - Mon Mar 31, 3:01PM CDT
--Fourth Quarter 2013 Highlights

Bovie Medical Corporation Fourth Quarter and Full Year 2013 Earnings Conference Call to be Held on Monday, March 31, 2014
Business Wire - Thu Mar 20, 10:22AM CDT
Bovie Medical Corporation (NYSE MKT: BVX), a manufacturer and marketer of electrosurgical products, today announced that it will issue financial results and corporate developments for the fourth quarter and full year 2013, following the close of market on Monday, March 31, 2014.

Bovie Medical Corporation Closes Strategic $7.0M Equity Investment Through Great Point Partners
Marketwire - Mon Dec 16, 6:30AM CST
Bovie Medical Corporation (the "Company" (NYSE MKT: BVX), a manufacturer and marketer of electrosurgical products, announced today that it completed a $7.0 million funding through Great Point Partners LLC (GPP). Gilford Securities Incorporated acted as sole placement agent.

Bovie Medical Corporation Announces J-Plasma(R) Accepted for Presentation at the Prestigious 42nd AAGL Annual Global Congress on Minimally Invasive Gynecology
Marketwire - Tue Aug 27, 7:02AM CDT
Bovie Medical Corporation (the "Company" (NYSE MKT: BVX), a manufacturer and marketer of electrosurgical products, is pleased to announce that the submission of a video and paper presentation, by noted Gynecological surgeons, Dr. Warren K. Volker and Dr. Melissa Gutierrez, has been accepted for presentation at the AAGL Global Congress to be held in Washington, D.C., November 10-14, 2013. The Congress is attended by several thousand surgeons from around the world, representing highly skilled thought leaders in their respective communities. Jeff Rencher, V.P. of Sales and Marketing for Surgical Products stated: "This acceptance supports Bovie's conviction that J-Plasma(R) is an innovative surgical tool that can benefit surgeons and their patients in many surgical procedures performed by gynecologists. Furthermore, the presentation should give J-Plasma(R) worldwide recognition."

Bovie Medical Corporation Reports Results for Three and Six-Months Ended June 30, 2013
Marketwire - Wed Aug 14, 7:30AM CDT
Bovie Medical Corporation (the "Company" (NYSE MKT: BVX), a manufacturer and marketer of electrosurgical products, today announced its financial results for the second quarter and six months ended June 30, 2013.

Bovie Medical Corporation's Annual Meeting of Shareholders Sees Royce T. Adkins, M.D., Report Favorably on J-Plasma(R)
Marketwire - Tue Jul 23, 7:02AM CDT
Bovie Medical Corporation (the "Company" (NYSE MKT: BVX), a manufacturer and marketer of electrosurgical products, today announced that Royce T. Adkins, M.D., a key opinion leader in Women's Health and regularly listed as one of "America's Top Obstetricians and Gynecologists" by Who's Who Best Doctors in America, addressed Bovie's Annual Meeting held on July 16, 2013 at 3:00 P.M. Dr. Adkins shared his and other surgeons' sentiments and conclusions on J-Plasma(R).

Royce T. Adkins, M.D., Reports Favorably On J-Plasma(R) At Bovie Medical Corporation's Annual Meeting of Shareholders
ACCESSWIRE - Fri Jul 19, 7:35AM CDT
MELVILLE, NY, July 19, 2013 -(eTeligis via ACCESSWIRE)- Bovie Medical Corporation (the "Company" (NYSE MKT: BVX), a manufacturer and marketer of electrosurgical products, today announced that Royce T. Adkins, M.D., a key opinion leader in Women's Health and regularly listed as one of "America's Top Obstetricians and Gynecologists" by Who's Who Best Doctors in America, addressed Bovie's Annual Meeting held on July 16, 2013 at 3:00 P.M. Dr. Adkins shared his and other surgeons' sentiments and conclusions on J-Plasma(R).

All Other Basic Inorganic Chemical Manufacturing Industry 2013 Q2 Edition: Industry's Revenue for 2012 was $27.6 Billion USD
M2 - Thu May 30, 11:06AM CDT
Research and Markets (http://www.researchandmarkets.com/research/ggvl66/all_other_basic) has announced the addition of Supplier Relations US, LLC's new report "All Other Basic Inorganic Chemical Manufacturing Industry in the U.S. and its International Trade [2013 Q2 Edition]" to their offering. This 2013 report's 184 pages and over 150 charts and tables cover the domestic market, global market and overseas growth opportunities. Find the latest data on shipments, inventory, international trade, and essential industry price indices available through March 2013. Relying on over a decade of historic data and sophisticated forecasting, the report projects industry trends through 2017. The report's broad scope includes topics from foreign trade to industry structure, while also diving into the details such as market sizes of products and players. Industry experts consistently subscribe to this quarterly-updated market research report. The industry's revenue for the year 2012 was reported at $27.6 billion USD, w

Bovie Medical Corporation Reports First Quarter Results and New Progress on J-Plasma(R)
Marketwire - Wed May 15, 7:30AM CDT
Bovie Medical Corporation (the "Company" (NYSE MKT: BVX), a manufacturer and marketer of electrosurgical products, today announced its financial results for the first quarter ended March 31, 2013.

Bovie Medical Corporation Announces Fiscal Year 2012 Financial Results
PR Newswire - Mon Apr 01, 7:30AM CDT
Bovie Medical Corporation (the "Company" (NYSE Amex: BVX), a manufacturer and marketer of electrosurgical products, today announced its financial results for the year ended December 31, 2012 and fourth quarter.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 24

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

Man Group PLC Highlights Its Strategic Disclosures on Tritax REIT

Updated Category News Views 148

Strategic Position Disclosure by Man Group PLC Man Group PLC is actively sharing its significant interests in the securities market, particularly focusing on its involvement with Tritax Big Box REIT plc. As a key player in the investment landscape, this disclosure marks an important step for the company regarding its strategic holdings. Key Information Pertaining to the...

Continue Reading
TalentLMS and Epignosis Lead the Way in GDPR Compliance

Updated Category News Views 720

TalentLMS and Epignosis Set the Standard for GDPR Compliance TalentLMS, along with its parent company Epignosis, has continuously led the way in providing a fully compliant Learning Management System (LMS) with regards to the General Data Protection Regulation (GDPR). Recent developments affirm that TalentLMS remains the only LMS globally to uphold its commitment to this...

Continue Reading
Zillow and Esusu Forge New Path to Boost Renters' Credit Scores

Updated Category News Views 283

Building Credit for Renters with Zillow and Esusu The recent collaboration between Zillow and Esusu marks a significant step towards empowering renters across the country to build their credit. This partnership allows any renter to report their on-time rent payments, significantly enhancing their credit profiles, for just $20 a year. How the Partnership Works Starting...

Continue Reading
iCrowdNewswire Leverages DeepL for Enhanced Global Communication

Updated Category News Views 121

iCrowdNewswire Enhances Multilingual Capabilities iCrowdNewswire, a prominent international press release distribution company, has embarked on a transformative journey to improve its multilingual services through the introduction of the DeepL API. The integration of DeepL's cutting-edge language AI technology has significantly boosted iCrowdNewswire’s ability to...

Continue Reading
Celebrating Excellence: Top Surgeons Recognized in Endocrine Care

Updated Category News Views 82

Exceptional Recognition for Leading Surgeons in Endocrine Surgery Dr. Jim Norman and Dr. Gary Clayman Acknowledged as Premier Specialists The Hospital for Endocrine Surgery is proud to announce that two of its distinguished surgeons, Dr. Jim Norman and Dr. Gary Clayman, have been honored in the prestigious Castle Connolly Top Doctors list for 2025. This remarkable...

Continue Reading